Open AccessBladder cancer: Twenty years of progress and the challenges that remain
Author(s) -
Lamm Donald L.
Publication year - 1998
Publication title -
ca: a cancer journal for clinicians
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 62.937
H-Index - 168
eISSN - 1542-4863
pISSN - 0007-9235
DOI - 10.3322/canjclin.48.5.263
Subject(s) - bladder cancer , medicine , incidence (geometry) , cancer , malignancy , mortality rate , oncology , physics , optics
The most obvious improvements in the care of patients with bladder cancer over the past 20 years are bacille Calmette-Guérin immunotherapy for superficial bladder cancer and cisplatin and methotrexate-based combination chemotherapy for advanced disease. The challenges that remain are prevention, early detection, and improved treatment of both superficial and advanced disease. Meeting these challenges requires research, financial investment, and public education.